nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyprylon—CYP2D6—Bicalutamide—prostate cancer	0.332	0.504	CbGbCtD
Methyprylon—CYP2D6—Abiraterone—prostate cancer	0.275	0.418	CbGbCtD
Methyprylon—CYP2D6—Doxorubicin—prostate cancer	0.0508	0.0773	CbGbCtD
Methyprylon—Ethosuximide—CYP3A43—prostate cancer	0.0449	0.653	CrCbGaD
Methyprylon—Ethosuximide—CYP3A5—prostate cancer	0.0113	0.164	CrCbGaD
Methyprylon—Ethosuximide—CYP2E1—prostate cancer	0.00773	0.113	CrCbGaD
Methyprylon—Ethosuximide—CYP3A4—prostate cancer	0.00487	0.0708	CrCbGaD
Methyprylon—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	0.000581	0.00212	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—ACHE—prostate cancer	0.000579	0.00211	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—AR—prostate cancer	0.000577	0.00211	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00057	0.00208	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—ACHE—prostate cancer	0.000568	0.00208	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000559	0.00204	CbGpPWpGaD
Methyprylon—GABRB3—Orphan transporters—CREBBP—prostate cancer	0.000559	0.00204	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—GNG5—prostate cancer	0.000558	0.00204	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000555	0.00203	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000555	0.00203	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—PRKACB—prostate cancer	0.000554	0.00202	CbGpPWpGaD
Methyprylon—GABRG2—Orphan transporters—CREBBP—prostate cancer	0.000549	0.002	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	0.000547	0.002	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000545	0.00199	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000545	0.00199	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—PRKACB—prostate cancer	0.000544	0.00199	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP3A5—prostate cancer	0.000543	0.00198	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP3A5—prostate cancer	0.000536	0.00196	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—prostate cancer	0.000528	0.00193	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—COMT—prostate cancer	0.000526	0.00192	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTA3—prostate cancer	0.000525	0.00192	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	0.000519	0.00189	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—GSTA3—prostate cancer	0.000517	0.00189	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—COMT—prostate cancer	0.000517	0.00189	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000504	0.00184	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—ACHE—prostate cancer	0.000497	0.00181	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	0.000495	0.00181	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000489	0.00179	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	0.000488	0.00178	CbGpPWpGaD
Methyprylon—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	0.000485	0.00177	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—BAD—prostate cancer	0.00048	0.00175	CbGpPWpGaD
Methyprylon—GABRA1—Orphan transporters—CREBBP—prostate cancer	0.00048	0.00175	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—TBXAS1—prostate cancer	0.00048	0.00175	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTA4—prostate cancer	0.00048	0.00175	CbGpPWpGaD
Methyprylon—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	0.000479	0.00175	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000477	0.00174	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000477	0.00174	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—PRKACB—prostate cancer	0.000475	0.00174	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—GSTA4—prostate cancer	0.000473	0.00173	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	0.000471	0.00172	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTA2—prostate cancer	0.000468	0.00171	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.000466	0.0017	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—APC—prostate cancer	0.000465	0.0017	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—SULT1A1—prostate cancer	0.000462	0.00169	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—IRS1—prostate cancer	0.000459	0.00168	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—SULT1A1—prostate cancer	0.000455	0.00166	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—COMT—prostate cancer	0.000452	0.00165	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTA1—prostate cancer	0.000451	0.00165	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00045	0.00164	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTO1—prostate cancer	0.000446	0.00163	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—NAT2—prostate cancer	0.000446	0.00163	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—GSK3B—prostate cancer	0.000446	0.00163	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000442	0.00161	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—GSTO1—prostate cancer	0.00044	0.00161	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—NAT2—prostate cancer	0.00044	0.00161	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP2C18—prostate cancer	0.000428	0.00156	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000425	0.00155	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP2C18—prostate cancer	0.000422	0.00154	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000416	0.00152	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—MAP2K1—prostate cancer	0.000411	0.0015	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000408	0.00149	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—COMT—prostate cancer	0.000403	0.00147	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—SULT2A1—prostate cancer	0.000398	0.00145	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—COMT—prostate cancer	0.000396	0.00145	CbGpPWpGaD
Methyprylon—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	0.000393	0.00144	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—SULT2A1—prostate cancer	0.000392	0.00143	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000387	0.00141	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—JAK2—prostate cancer	0.000375	0.00137	CbGpPWpGaD
Methyprylon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000374	0.00137	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—GPX3—prostate cancer	0.000374	0.00137	CbGpPWpGaD
Methyprylon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000368	0.00134	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000367	0.00134	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000361	0.00132	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000357	0.0013	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—HPGDS—prostate cancer	0.000357	0.0013	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP2C19—prostate cancer	0.000354	0.00129	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP2C19—prostate cancer	0.000349	0.00128	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000349	0.00128	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000347	0.00127	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—COMT—prostate cancer	0.000346	0.00126	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTT1—prostate cancer	0.000346	0.00126	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000343	0.00125	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP2A6—prostate cancer	0.000342	0.00125	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—AKR1C3—prostate cancer	0.000328	0.0012	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—CASP3—prostate cancer	0.000328	0.0012	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP17A1—prostate cancer	0.000327	0.0012	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP17A1—prostate cancer	0.000323	0.00118	CbGpPWpGaD
Methyprylon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000321	0.00117	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—CTNNB1—prostate cancer	0.000316	0.00115	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000315	0.00115	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—NCOA2—prostate cancer	0.000312	0.00114	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.0003	0.00109	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000298	0.00109	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000292	0.00107	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP2E1—prostate cancer	0.000291	0.00106	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP2E1—prostate cancer	0.000287	0.00105	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—SRC—prostate cancer	0.000285	0.00104	CbGpPWpGaD
Methyprylon—GABRB3—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000281	0.00103	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000281	0.00103	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP3A4—prostate cancer	0.00028	0.00102	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP3A4—prostate cancer	0.000276	0.00101	CbGpPWpGaD
Methyprylon—GABRG2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000276	0.00101	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000276	0.00101	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP1B1—prostate cancer	0.000276	0.00101	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000276	0.00101	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—STAT3—prostate cancer	0.000275	0.001	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP1B1—prostate cancer	0.000272	0.000992	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000268	0.000978	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GGT1—prostate cancer	0.000267	0.000974	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000264	0.000963	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000263	0.00096	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—NCOA1—prostate cancer	0.000263	0.00096	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP19A1—prostate cancer	0.000259	0.000946	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000256	0.000933	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP19A1—prostate cancer	0.000256	0.000933	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000254	0.000928	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—RXRA—prostate cancer	0.00025	0.000913	CbGpPWpGaD
Methyprylon—GABRA1—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000242	0.000882	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000241	0.00088	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—COMT—prostate cancer	0.000241	0.000879	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTP1—prostate cancer	0.00024	0.000875	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—COMT—prostate cancer	0.000238	0.000867	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000237	0.000864	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—GSTP1—prostate cancer	0.000236	0.000863	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000236	0.000863	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000232	0.000848	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.00023	0.000839	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000225	0.000822	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000224	0.000817	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000221	0.000807	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—GSTM1—prostate cancer	0.00022	0.000804	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—GSTM1—prostate cancer	0.000217	0.000793	CbGpPWpGaD
Methyprylon—GABRB3—Neuronal System—MDM2—prostate cancer	0.000216	0.000787	CbGpPWpGaD
Methyprylon—GABRG2—Neuronal System—MDM2—prostate cancer	0.000212	0.000773	CbGpPWpGaD
Methyprylon—CYP2D6—Biological oxidations—CYP1A1—prostate cancer	0.000209	0.000763	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—HAO1—prostate cancer	0.000206	0.000753	CbGpPWpGaD
Methyprylon—CYP2D6—Metapathway biotransformation—CYP1A1—prostate cancer	0.000206	0.000752	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000203	0.000741	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000193	0.000705	CbGpPWpGaD
Methyprylon—GABRA1—Neuronal System—MDM2—prostate cancer	0.000185	0.000676	CbGpPWpGaD
Methyprylon—GABRB3—BDNF signaling pathway—AKT1—prostate cancer	0.000177	0.000648	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000172	0.000628	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000169	0.000616	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—TST—prostate cancer	0.000168	0.000613	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CSAD—prostate cancer	0.000168	0.000613	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—ADI1—prostate cancer	0.000168	0.000613	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CBR1—prostate cancer	0.000168	0.000613	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PSAT1—prostate cancer	0.000168	0.000613	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GRHL1—prostate cancer	0.000168	0.000613	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—UGT2B17—prostate cancer	0.000156	0.00057	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CKMT2—prostate cancer	0.000156	0.00057	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GRHPR—prostate cancer	0.000156	0.00057	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—UGT2B15—prostate cancer	0.000156	0.00057	CbGpPWpGaD
Methyprylon—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000155	0.000565	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000148	0.000539	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NAGLU—prostate cancer	0.000147	0.000536	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—AOX1—prostate cancer	0.000147	0.000536	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—RFK—prostate cancer	0.000147	0.000536	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTM3—prostate cancer	0.000147	0.000536	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—SULT2B1—prostate cancer	0.000147	0.000536	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—MBTPS1—prostate cancer	0.000147	0.000536	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PGAM2—prostate cancer	0.000147	0.000536	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NAT1—prostate cancer	0.000139	0.000508	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—DEGS1—prostate cancer	0.000139	0.000508	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—AMACR—prostate cancer	0.000139	0.000508	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—SRD5A2—prostate cancer	0.000139	0.000508	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP3A43—prostate cancer	0.000139	0.000508	CbGpPWpGaD
Methyprylon—GABRB3—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000136	0.000498	CbGpPWpGaD
Methyprylon—GABRG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000134	0.000489	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—HSD17B1—prostate cancer	0.000133	0.000485	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—B4GALT4—prostate cancer	0.000118	0.000432	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—HPGD—prostate cancer	0.000118	0.000432	CbGpPWpGaD
Methyprylon—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000117	0.000428	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—TNFRSF21—prostate cancer	0.000111	0.000406	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP7B1—prostate cancer	0.000108	0.000395	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—MTAP—prostate cancer	0.000108	0.000395	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—SULT1E1—prostate cancer	0.000106	0.000385	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—SRD5A1—prostate cancer	0.000106	0.000385	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—HSD17B3—prostate cancer	0.000101	0.000367	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—ACSL4—prostate cancer	0.000101	0.000367	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PHGDH—prostate cancer	9.65e-05	0.000352	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—UMPS—prostate cancer	9.65e-05	0.000352	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—ARG2—prostate cancer	9.65e-05	0.000352	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—LDHB—prostate cancer	9.46e-05	0.000346	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP3A5—prostate cancer	9.29e-05	0.000339	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—TCN2—prostate cancer	8.97e-05	0.000328	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTA3—prostate cancer	8.97e-05	0.000328	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PDHA1—prostate cancer	8.97e-05	0.000328	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—UCP3—prostate cancer	8.97e-05	0.000328	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—HSD3B1—prostate cancer	8.56e-05	0.000312	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—SLC22A3—prostate cancer	8.56e-05	0.000312	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—TBXAS1—prostate cancer	8.2e-05	0.0003	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTA4—prostate cancer	8.2e-05	0.0003	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTA2—prostate cancer	8e-05	0.000292	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—ABCG5—prostate cancer	7.9e-05	0.000288	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—SULT1A1—prostate cancer	7.9e-05	0.000288	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTA1—prostate cancer	7.71e-05	0.000282	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTO1—prostate cancer	7.63e-05	0.000279	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—HSD3B2—prostate cancer	7.63e-05	0.000279	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NAT2—prostate cancer	7.63e-05	0.000279	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PLCB2—prostate cancer	7.31e-05	0.000267	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—LRP2—prostate cancer	7.31e-05	0.000267	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP2C18—prostate cancer	7.31e-05	0.000267	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—P4HB—prostate cancer	7.17e-05	0.000262	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—SLC22A1—prostate cancer	6.98e-05	0.000255	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—SULT2A1—prostate cancer	6.8e-05	0.000248	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—MED12—prostate cancer	6.69e-05	0.000244	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GNG5—prostate cancer	6.64e-05	0.000242	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NCOA3—prostate cancer	6.39e-05	0.000233	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—HPGDS—prostate cancer	6.1e-05	0.000223	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP2C19—prostate cancer	6.06e-05	0.000221	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—ACHE—prostate cancer	5.91e-05	0.000216	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTT1—prostate cancer	5.91e-05	0.000216	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP2A6—prostate cancer	5.85e-05	0.000213	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—AKR1C3—prostate cancer	5.69e-05	0.000208	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PRKACB—prostate cancer	5.66e-05	0.000207	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.6e-05	0.000204	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NCOA2—prostate cancer	5.33e-05	0.000195	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.09e-05	0.000186	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.97e-05	0.000182	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NQO1—prostate cancer	4.92e-05	0.000179	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—TH—prostate cancer	4.84e-05	0.000177	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.79e-05	0.000175	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.71e-05	0.000172	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GGT1—prostate cancer	4.56e-05	0.000167	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NCOA1—prostate cancer	4.5e-05	0.000164	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.43e-05	0.000162	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—RXRA—prostate cancer	4.28e-05	0.000156	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—COMT—prostate cancer	4.12e-05	0.00015	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTP1—prostate cancer	4.1e-05	0.00015	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—ITPR1—prostate cancer	4.03e-05	0.000147	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—TYMS—prostate cancer	3.81e-05	0.000139	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—GSTM1—prostate cancer	3.77e-05	0.000138	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—LPL—prostate cancer	3.7e-05	0.000135	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.57e-05	0.00013	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—ERCC2—prostate cancer	3.54e-05	0.000129	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—MTHFR—prostate cancer	3.33e-05	0.000122	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PPARA—prostate cancer	3.27e-05	0.000119	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CAV1—prostate cancer	3.07e-05	0.000112	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.8e-05	0.000102	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—INS—prostate cancer	2.65e-05	9.67e-05	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—CREBBP—prostate cancer	2.59e-05	9.47e-05	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.46e-05	8.98e-05	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—NOS3—prostate cancer	2.32e-05	8.48e-05	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.14e-05	7.83e-05	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PTGS2—prostate cancer	2.12e-05	7.75e-05	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PTEN—prostate cancer	1.85e-05	6.76e-05	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—EP300—prostate cancer	1.77e-05	6.45e-05	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.31e-05	4.77e-05	CbGpPWpGaD
Methyprylon—CYP2D6—Metabolism—AKT1—prostate cancer	1.07e-05	3.9e-05	CbGpPWpGaD
